1-1 of 1
Lejla Zahiragic, MD
Close
Sort by
Journal Articles

Bevacizumab Reduces VEGF Expression in Patients with Relapsed and/or Refractory Acute Myeloid Leukaemia (AML) without Clinical Antileukemic Activity.

Lejla Zahiragic, MD, Christoph Schliemann, MD, Ralf Bieker, MD, Wolfgang E. Berdel, MD, Rolf M. Mesters, MD
Journal: Blood
Blood (2006) 108 (11): 4543.
https://doi.org/10.1182/blood.V108.11.4543.4543
Published: 2006